etravirine has been researched along with bms-626529 in 2 studies
| Studies (etravirine) | Trials (etravirine) | Recent Studies (post-2010) (etravirine) | Studies (bms-626529) | Trials (bms-626529) | Recent Studies (post-2010) (bms-626529) |
|---|---|---|---|---|---|
| 572 | 90 | 321 | 28 | 3 | 28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baidya, ATK; Das, B; Kumar, R; Mathew, AT; Yadav, AK | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for etravirine and bms-626529
| Article | Year |
|---|---|
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.
Topics: Drug Discovery; Hydrogen Bonding; Molecular Structure; Prodrugs; Solubility | 2022 |
1 other study(ies) available for etravirine and bms-626529
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |